Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial

Table 3

Descriptive statistics for the counts of predominant bacteria between treatment groups by measurement occasion.

Predominant bacterial species measures	Week	⁢Probiotic group: counts of CFU/g faeces					Placebo group: counts of CFU/g faeces
			Mean	SD	Min	Max		Mean	SD	Min	Max
Bacteroides sp.	0	23	4.1	2.72	1.7	11.9	22	4.0	2.29	1.5	8.0
	12	21	5.6	5.39	1.9	24.0	21	4.6	2.57	1.7	12.4
Clostridia sp.	0	23	4.4	2.09	1.8	9.1	22	3.8	1.62	1.9	7.4
	12	21	4.4	2.93	1.6	10.7	21	4.6	2.42	1.4	9.9
Prevotella sp.	0	23	4.2	2.59	1.5	13.6	22	3.2	1.67	1.6	7.4
	12	21	3.3	1.73	1.7	8.5	21	2.9	1.33	1.7	5.8
Fusobacteria sp.	0	23	4.5	3.51	1.9	13.2	22	4.3	3.06	1.7	13.4
	12	21	4.9	7.18	1.4	34.8	21	3.8	2.84	1.3	10.2
Streptomyces sp.	0	23	3.9	1.98	1.7	9.9	22	3.0	1.34	1.6	6.7
	12	21	4.1	2.15	1.5	9.2	21	3.2	2.04	1.7	9.8
Mycoplasma sp.	0	23	3.3	1.34	1.6	6.4	22	3.4	1.73	1.7	8.3
	12	21	4.3	2.46	1.9	9.8	21	2.9	1.13	1.6	5.4
Lactobacillus sp.	0	23	4.3	2.30	1.8	11.3	22	6.5	6.41	1.8	29.8
	12	21	4.6	3.48	1.5	17.3	21	6.2	6.63	2.1	32.0
Bifidobacteria sp.	0	23	5.2	2.91	2.2	11.8	22	5.1	2.41	1.8	9.5
	12	21	4.8	3.22	1.9	15.2	21	3.4	1.45	1.5	7.6
Escherichia coli sp.	0	23	3.7	1.92	1.6	8.3	22	3.3	1.44	1.6	6.4
	12	21	5.0	2.86	1.5	11.7	21	4.0	2.36	1.7	10.2
Predominant bacterial total counts	0	23	38.06	8.95	23.3	58.7	22	36.8	10.75	23.6	75.3
	12	21	41.34	15.35	22.3	73.4	21	36.0	12.18	24.5	68.0

A count of 4.1 = 4.1 E7 CFU/g is read as 41 million colony forming units per gram of faeces.